drugset / Trial / NCT02046187

Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma

NCT02046187

Phase 1/2 Terminated 14 enrolled St. Joseph's Hospital and Medical Center, Phoenix
NaSingle-groupOpen-labelTreatment

Summary

This study aims to see if reducing blood sugar and increasing ketones (a metabolic product that comes from using fats for energy) can increase survival and enhance the the effects of standard radiation and chemotherapy treatments used to treat glioblastoma multiforme (GBM). These changes occur from use of a ketogenic diet. This research has 2 goals: 1. Show that patients can tolerate the diet and maintain low blood glucose and high blood ketone levels. 2. Show if this diet enhances the effectiveness of standard treatment by prolonging survival of patients with a GBM.

Timeline

Start
2013-10
Primary completion
2017-02
Completion
2017-02

Drugs

EvaluationDrugModalityDoseRoute
Background Temozolomide Small molecule 150 mg/kg Oral
Background Temozolomide Small molecule 200 mg/kg Oral

Indications